[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 2016

On the US Preventive Services Task Force Statement on Screening for Lipid Disorders in Children and AdolescentsOne Step Forward and 2 Steps Sideways

Author Affiliations
  • 1Department of Pediatrics, University of Colorado School of Medicine, Aurora
  • 2Children’s Hospital Colorado, Aurora
JAMA Pediatr. 2016;170(10):932-934. doi:10.1001/jamapediatrics.2016.2315

In the current issue of JAMA, the US Preventive Services Task Force (USPSTF) has published the results of its most recent evidence reviews and recommendations on screening for lipid disorders in children and adolescents.13 The recommendation statement is an I statement, meaning that the USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. This is an update of the last statement, which had a similar recommendation and grade.4

First Page Preview View Large
First page PDF preview
First page PDF preview